{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T04:12:51Z","timestamp":1784693571309,"version":"3.55.0"},"reference-count":74,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","theclinics.com","pediatric.theclinics.com","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pediatric Clinics of North America"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1016\/j.pcl.2014.08.010","type":"journal-article","created":{"date-parts":[[2014,9,22]],"date-time":"2014-09-22T02:47:31Z","timestamp":1411354051000},"page":"1243-1257","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":68,"title":["Update on the Evaluation and Treatment of Osteogenesis Imperfecta"],"prefix":"10.1016","volume":"61","author":[{"given":"Jennifer","family":"Harrington","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Etienne","family":"Sochett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Howard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.pcl.2014.08.010_bib1","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1002\/ajmg.a.35327","article-title":"Analysis of skeletal dysplasias in the utah population","volume":"158A","author":"Stevenson","year":"2012","journal-title":"Am J Med Genet A"},{"issue":"2","key":"10.1016\/j.pcl.2014.08.010_bib2","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/j.1399-0004.1989.tb02912.x","article-title":"Birth prevalence rates of skeletal dysplasias","volume":"35","author":"Stoll","year":"1989","journal-title":"Clin Genet"},{"issue":"1","key":"10.1016\/j.pcl.2014.08.010_bib3","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/BF00297295","article-title":"Osteogenesis imperfecta: a clinical study of the first ten years of life","volume":"50","author":"Vetter","year":"1992","journal-title":"Calcif Tissue Int"},{"issue":"2","key":"10.1016\/j.pcl.2014.08.010_bib4","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1136\/jmg.16.2.101","article-title":"Genetic heterogeneity in osteogenesis imperfecta","volume":"16","author":"Sillence","year":"1979","journal-title":"J\u00a0Med Genet"},{"issue":"3","key":"10.1016\/j.pcl.2014.08.010_bib5","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1093\/hmg\/ddn374","article-title":"Mutation and polymorphism spectrum in osteogenesis imperfecta type II: implications for genotype-phenotype relationships","volume":"18","author":"Bodian","year":"2009","journal-title":"Hum Mol Genet"},{"issue":"4","key":"10.1016\/j.pcl.2014.08.010_bib6","first-page":"638","article-title":"Osteogenesis imperfecta type I: molecular heterogeneity for COL1A1 null alleles of type I collagen","volume":"55","author":"Willing","year":"1994","journal-title":"Am J Hum Genet"},{"issue":"1","key":"10.1016\/j.pcl.2014.08.010_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0945-053X(99)00056-6","article-title":"Nonsense mutations in the COL1A1 gene preferentially reduce nuclear levels of mRNA but not hnRNA in osteogenesis imperfecta type I cell strains","volume":"19","author":"Slayton","year":"2000","journal-title":"Matrix Biol"},{"issue":"3","key":"10.1016\/j.pcl.2014.08.010_bib8","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/humu.20429","article-title":"Consortium for osteogenesis imperfecta mutations in the helical domain of type I collagen: regions rich in lethal mutations align with collagen binding sites for integrins and proteoglycans","volume":"28","author":"Marini","year":"2007","journal-title":"Hum Mutat"},{"issue":"8","key":"10.1016\/j.pcl.2014.08.010_bib9","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1136\/jcp.49.8.627","article-title":"Causes of death in osteogenesis imperfecta","volume":"49","author":"McAllion","year":"1996","journal-title":"J\u00a0Clin Pathol"},{"issue":"9","key":"10.1016\/j.pcl.2014.08.010_bib10","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1359\/jbmr.2000.15.9.1650","article-title":"Type V osteogenesis imperfecta: a new form of brittle bone disease","volume":"15","author":"Glorieux","year":"2000","journal-title":"J\u00a0Bone Miner Res"},{"issue":"12","key":"10.1016\/j.pcl.2014.08.010_bib11","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.2106\/JBJS.F.01287","article-title":"Radial head dislocation and subluxation in osteogenesis imperfecta","volume":"89","author":"Fassier","year":"2007","journal-title":"J\u00a0Bone Joint Surg Am"},{"issue":"2","key":"10.1016\/j.pcl.2014.08.010_bib12","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.ajhg.2012.06.011","article-title":"A\u00a0mutation in the 5'-UTR of IFITM5 creates an in-frame start codon and causes autosomal-dominant osteogenesis imperfecta type V with hyperplastic callus","volume":"91","author":"Semler","year":"2012","journal-title":"Am J Hum Genet"},{"issue":"8","key":"10.1016\/j.pcl.2014.08.010_bib13","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.1210\/jc.2013-1505","article-title":"New genes in bone development: what's new in osteogenesis imperfecta","volume":"98","author":"Marini","year":"2013","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.pcl.2014.08.010_bib14","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.ajhg.2011.01.015","article-title":"Exome sequencing identifies truncating mutations in human SERPINF1 in autosomal-recessive osteogenesis imperfecta","volume":"88","author":"Becker","year":"2011","journal-title":"Am J Hum Genet"},{"issue":"6","key":"10.1016\/j.pcl.2014.08.010_bib15","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1056\/NEJMoa0907705","article-title":"Lack of cyclophilin B in osteogenesis imperfecta with normal collagen folding","volume":"362","author":"Barnes","year":"2010","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.pcl.2014.08.010_bib16","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.ajhg.2010.02.022","article-title":"Mutations in the gene encoding the RER protein FKBP65 cause autosomal-recessive osteogenesis imperfecta","volume":"86","author":"Alanay","year":"2010","journal-title":"Am J Hum Genet"},{"issue":"2","key":"10.1016\/j.pcl.2014.08.010_bib17","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1002\/humu.21647","article-title":"Identification of a mutation causing deficient BMP1\/mTLD proteolytic activity in autosomal recessive osteogenesis imperfecta","volume":"33","author":"Martinez-Glez","year":"2012","journal-title":"Hum Mutat"},{"issue":"1","key":"10.1016\/j.pcl.2014.08.010_bib18","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ajhg.2010.05.016","article-title":"Identification of a frameshift mutation in osterix in a patient with recessive osteogenesis imperfecta","volume":"87","author":"Lapunzina","year":"2010","journal-title":"Am J Hum Genet"},{"issue":"19","key":"10.1016\/j.pcl.2014.08.010_bib19","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1056\/NEJMoa1215458","article-title":"WNT1 mutations in early-onset osteoporosis and osteogenesis imperfecta","volume":"368","author":"Laine","year":"2013","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.pcl.2014.08.010_bib20","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1258\/0022215011907442","article-title":"How common is hearing impairment in osteogenesis imperfecta?","volume":"115","author":"Paterson","year":"2001","journal-title":"J\u00a0Laryngol Otol"},{"issue":"7","key":"10.1016\/j.pcl.2014.08.010_bib21","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/s004310051322","article-title":"Hearing loss in children with osteogenesis imperfecta","volume":"159","author":"Kuurila","year":"2000","journal-title":"Eur J Pediatr"},{"issue":"2","key":"10.1016\/j.pcl.2014.08.010_bib22","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/j.1365-263X.2010.01033.x","article-title":"Dentinogenesis imperfecta in children with osteogenesis imperfecta: a clinical and ultrastructural study","volume":"20","author":"Majorana","year":"2010","journal-title":"Int J Paediatr Dent"},{"issue":"2","key":"10.1016\/j.pcl.2014.08.010_bib23","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S1079-2104(99)70272-6","article-title":"Evaluation of oral problems in an osteogenesis imperfecta population","volume":"87","author":"O'Connell","year":"1999","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"issue":"7","key":"10.1016\/j.pcl.2014.08.010_bib24","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1001\/archderm.138.7.909","article-title":"The mechanical properties of skin in osteogenesis imperfecta","volume":"138","author":"Hansen","year":"2002","journal-title":"Arch Dermatol"},{"issue":"3","key":"10.1016\/j.pcl.2014.08.010_bib25","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/8756-3282(94)00046-8","article-title":"Hypercalciuria in osteogenesis imperfecta: a follow-up study to assess renal effects","volume":"16","author":"Chines","year":"1995","journal-title":"Bone"},{"issue":"1","key":"10.1016\/j.pcl.2014.08.010_bib26","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1540-8175.2009.00973.x","article-title":"Valvular heart disease in osteogenesis imperfecta: presentation of a case and review of the literature","volume":"27","author":"Bonita","year":"2010","journal-title":"Echocardiography"},{"issue":"6","key":"10.1016\/j.pcl.2014.08.010_bib27","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1016\/0002-8703(83)90055-8","article-title":"Cardiovascular abnormalities in osteogenesis imperfecta","volume":"106","author":"White","year":"1983","journal-title":"Am Heart J"},{"issue":"12","key":"10.1016\/j.pcl.2014.08.010_bib28","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1212\/WNL.43.12.2603","article-title":"Communicating hydrocephalus, basilar invagination, and other neurologic features in osteogenesis imperfecta","volume":"43","author":"Charnas","year":"1993","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/j.pcl.2014.08.010_bib29","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/nrendo.2011.81","article-title":"New perspectives on osteogenesis imperfecta","volume":"7","author":"Forlino","year":"2011","journal-title":"Nat Rev Endocrinol"},{"issue":"10","key":"10.1016\/j.pcl.2014.08.010_bib30","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1007\/s00381-008-0602-z","article-title":"Specific entities affecting the craniocervical region: osteogenesis imperfecta and related osteochondrodysplasias: Medical and surgical management of basilar impression","volume":"24","author":"Menezes","year":"2008","journal-title":"Childs Nerv Syst"},{"issue":"9","key":"10.1016\/j.pcl.2014.08.010_bib31","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1002\/jbmr.1942","article-title":"Skeletal clinical characteristics of osteogenesis imperfecta caused by haploinsufficiency mutations in COL1A1","volume":"28","author":"Ben Amor","year":"2013","journal-title":"J\u00a0Bone Miner Res"},{"issue":"7","key":"10.1016\/j.pcl.2014.08.010_bib32","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.2106\/00004623-199307000-00009","article-title":"Displaced fractures of the apophysis of the olecranon in children who have osteogenesis imperfecta","volume":"75","author":"Stott","year":"1993","journal-title":"J\u00a0Bone Joint Surg Am"},{"issue":"1","key":"10.1016\/j.pcl.2014.08.010_bib33","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1097\/BPO.0b013e318279c55d","article-title":"Fractures at diagnosis in infants and children with osteogenesis imperfecta","volume":"33","author":"Greeley","year":"2013","journal-title":"J\u00a0Pediatr Orthop"},{"issue":"4","key":"10.1016\/j.pcl.2014.08.010_bib34","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1359\/jbmr.2003.18.4.610","article-title":"Bone mass, size, and density in children and adolescents with osteogenesis imperfecta: effect of intravenous pamidronate therapy","volume":"18","author":"Rauch","year":"2003","journal-title":"J\u00a0Bone Miner Res"},{"issue":"5","key":"10.1016\/j.pcl.2014.08.010_bib35","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.apmr.2003.08.085","article-title":"Osteogenesis imperfecta in childhood: Impairment and disability. A prospective study with 4-year follow-up","volume":"85","author":"Engelbert","year":"2004","journal-title":"Arch Phys Med Rehabil"},{"issue":"3","key":"10.1016\/j.pcl.2014.08.010_bib36","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1097\/01.bpo.0000152940.10487.c9","article-title":"Bone healing in children with osteogenesis imperfecta treated with bisphosphonates","volume":"25","author":"Pizones","year":"2005","journal-title":"J\u00a0Pediatr Orthop"},{"key":"10.1016\/j.pcl.2014.08.010_bib37","series-title":"Surgical techniques in orthopaedics and traumatology","first-page":"1","article-title":"Surgical management of osteogenesis imperfecta","author":"Fassier","year":"2003"},{"issue":"1","key":"10.1016\/j.pcl.2014.08.010_bib38","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1302\/0301-620X.64B1.7068718","article-title":"Scoliosis associated with osteogenesis imperfecta","volume":"64","author":"Yong-Hing","year":"1982","journal-title":"J\u00a0Bone Joint Surg Br"},{"issue":"7","key":"10.1016\/j.pcl.2014.08.010_bib39","doi-asserted-by":"crossref","first-page":"925","DOI":"10.2106\/00004623-197860070-00009","article-title":"The spine in osteogenesis imperfecta","volume":"60","author":"Benson","year":"1978","journal-title":"J\u00a0Bone Joint Surg Am"},{"issue":"6","key":"10.1016\/j.pcl.2014.08.010_bib40","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S0035-1040(04)70426-2","article-title":"Posterior spinal fusion for kypho-scoliosis associated with osteogenesis imperfecta: long-term results","volume":"90","author":"Topouchian","year":"2004","journal-title":"Rev Chir Orthop Reparatrice Appar Mot"},{"issue":"13","key":"10.1016\/j.pcl.2014.08.010_bib41","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1097\/BRS.0b013e3181a39646","article-title":"Prevalence of vertebral pars defects (spondylolysis) in a population with osteogenesis imperfecta","volume":"34","author":"Verra","year":"2009","journal-title":"Spine (Phila Pa 1976)"},{"issue":"7","key":"10.1016\/j.pcl.2014.08.010_bib42","doi-asserted-by":"crossref","first-page":"E191","DOI":"10.1097\/01.brs.0000157471.44284.a2","article-title":"Surgical management of severe cervical kyphosis with myelopathy in osteogenesis imperfecta: a case report","volume":"30","author":"Daivajna","year":"2005","journal-title":"Spine (Phila Pa 1976)"},{"issue":"3","key":"10.1016\/j.pcl.2014.08.010_bib43","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3171\/PED\/2008\/1\/3\/229","article-title":"Neurosurgical implications of osteogenesis imperfecta in children. report of 4 cases","volume":"1","author":"Sasaki-Adams","year":"2008","journal-title":"J\u00a0Neurosurg Pediatr"},{"issue":"9","key":"10.1016\/j.pcl.2014.08.010_bib44","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1002\/jbmr.413","article-title":"Relationship between vitamin D status and bone mineralization, mass, and metabolism in children with osteogenesis imperfecta: histomorphometric study","volume":"26","author":"Edouard","year":"2011","journal-title":"J\u00a0Bone Miner Res"},{"issue":"Suppl 2","key":"10.1016\/j.pcl.2014.08.010_bib45","doi-asserted-by":"crossref","first-page":"S150","DOI":"10.1542\/peds.2006-2023H","article-title":"Bisphosphonates: mode of action and pharmacology","volume":"119","author":"Russell","year":"2007","journal-title":"Pediatrics"},{"issue":"9","key":"10.1016\/j.pcl.2014.08.010_bib46","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1172\/JCI0215952","article-title":"The effects of intravenous pamidronate on the bone tissue of children and adolescents with osteogenesis imperfecta","volume":"110","author":"Rauch","year":"2002","journal-title":"J\u00a0Clin Invest"},{"issue":"14","key":"10.1016\/j.pcl.2014.08.010_bib47","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1056\/NEJM199810013391402","article-title":"Cyclic administration of pamidronate in children with severe osteogenesis imperfecta","volume":"339","author":"Glorieux","year":"1998","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.pcl.2014.08.010_bib48","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.bone.2006.04.004","article-title":"Vertebral morphometry in children and adolescents with osteogenesis imperfecta: effect of intravenous pamidronate treatment","volume":"39","author":"Land","year":"2006","journal-title":"Bone"},{"issue":"8","key":"10.1016\/j.pcl.2014.08.010_bib49","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1111\/j.1651-2227.2007.00390.x","article-title":"Effect of intravenous pamidronate therapy on everyday activities in children with osteogenesis imperfecta","volume":"96","author":"Lowing","year":"2007","journal-title":"Acta Paediatr"},{"issue":"9419","key":"10.1016\/j.pcl.2014.08.010_bib50","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/S0140-6736(04)16101-1","article-title":"Skeletal effects and functional outcome with olpadronate in children with osteogenesis imperfecta: a 2-year randomised placebo-controlled study","volume":"363","author":"Sakkers","year":"2004","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.pcl.2014.08.010_bib51","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1097\/01.bpo.0000176162.78980.ed","article-title":"Impact of alendronate on quality of life in children with osteogenesis imperfecta","volume":"25","author":"Seikaly","year":"2005","journal-title":"J\u00a0Pediatr Orthop"},{"issue":"2","key":"10.1016\/j.pcl.2014.08.010_bib52","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1210\/jc.2010-0636","article-title":"Alendronate for the treatment of pediatric osteogenesis imperfecta: a randomized placebo-controlled study","volume":"96","author":"Ward","year":"2011","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"9902","key":"10.1016\/j.pcl.2014.08.010_bib53","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1016\/S0140-6736(13)61091-0","article-title":"Risedronate in children with osteogenesis imperfecta: a randomised, double-blind, placebo-controlled trial","volume":"382","author":"Bishop","year":"2013","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.pcl.2014.08.010_bib54","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1359\/JBMR.050109","article-title":"Controlled trial of pamidronate in children with types III and IV osteogenesis imperfecta confirms vertebral gains but not short-term functional improvement","volume":"20","author":"Letocha","year":"2005","journal-title":"J\u00a0Bone Miner Res"},{"issue":"5","key":"10.1016\/j.pcl.2014.08.010_bib55","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1359\/JBMR.041232","article-title":"Intravenous neridronate in children with osteogenesis imperfecta: a randomized controlled study","volume":"20","author":"Gatti","year":"2005","journal-title":"J\u00a0Bone Miner Res"},{"issue":"1","key":"10.1016\/j.pcl.2014.08.010_bib56","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1359\/JBMR.051006","article-title":"Two-year clinical trial of oral alendronate versus intravenous pamidronate in children with osteogenesis imperfecta","volume":"21","author":"DiMeglio","year":"2006","journal-title":"J\u00a0Bone Miner Res"},{"issue":"5\u20136","key":"10.1016\/j.pcl.2014.08.010_bib57","first-page":"485","article-title":"Safety and efficacy of a 1-year treatment with zoledronic acid compared with pamidronate in children with osteogenesis imperfecta","volume":"25","author":"Barros","year":"2012","journal-title":"J\u00a0Pediatr Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.pcl.2014.08.010_bib58","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1210\/jc.2005-2413","article-title":"Pamidronate in children and adolescents with osteogenesis imperfecta: effect of treatment discontinuation","volume":"91","author":"Rauch","year":"2006","journal-title":"J\u00a0Pediatr Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.pcl.2014.08.010_bib59","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s00774-007-0782-8","article-title":"Alendronate treatment promotes bone formation with a less anisotropic microstructure during intramembranous ossification in rats","volume":"26","author":"Kashii","year":"2008","journal-title":"J\u00a0Bone Miner Metab"},{"issue":"1","key":"10.1016\/j.pcl.2014.08.010_bib60","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s11832-011-0380-0","article-title":"Changing pattern of femoral fractures in osteogenesis imperfecta with prolonged use of bisphosphonates","volume":"6","author":"Nicolaou","year":"2012","journal-title":"J\u00a0Child Orthop"},{"issue":"3","key":"10.1016\/j.pcl.2014.08.010_bib61","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.bone.2007.05.002","article-title":"Acute phase response and mineral status following low dose intravenous zoledronic acid in children","volume":"41","author":"Munns","year":"2007","journal-title":"Bone"},{"issue":"11","key":"10.1016\/j.pcl.2014.08.010_bib62","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1359\/JBMR.040814","article-title":"Delayed osteotomy but not fracture healing in pediatric osteogenesis imperfecta patients receiving pamidronate","volume":"19","author":"Munns","year":"2004","journal-title":"J\u00a0Bone Miner Res"},{"issue":"6","key":"10.1016\/j.pcl.2014.08.010_bib63","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/S1470-2045(06)70726-4","article-title":"Bisphosphonate-associated osteonecrosis: a long-term complication of bisphosphonate treatment","volume":"7","author":"Migliorati","year":"2006","journal-title":"Lancet Oncol"},{"issue":"9","key":"10.1016\/j.pcl.2014.08.010_bib64","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1007\/BF03349263","article-title":"Guidelines for the treatment of growth hormone excess and growth hormone deficiency in adults","volume":"31","author":"Giustina","year":"2008","journal-title":"J\u00a0Endocrinol Invest"},{"issue":"2","key":"10.1016\/j.pcl.2014.08.010_bib65","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/ajmg.1320450223","article-title":"Evaluation of growth hormone axis and responsiveness to growth stimulation of short children with osteogenesis imperfecta","volume":"45","author":"Marini","year":"1993","journal-title":"Am J Med Genet"},{"issue":"3","key":"10.1016\/j.pcl.2014.08.010_bib66","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/S0022-3476(96)70077-X","article-title":"Growth hormone treatment in osteogenesis imperfecta with quantitative defect of type I collagen synthesis","volume":"129","author":"Antoniazzi","year":"1996","journal-title":"J\u00a0Pediatr"},{"issue":"3","key":"10.1016\/j.pcl.2014.08.010_bib67","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1530\/EJE-10-0208","article-title":"GH in combination with bisphosphonate treatment in osteogenesis imperfecta","volume":"163","author":"Antoniazzi","year":"2010","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"10.1016\/j.pcl.2014.08.010_bib68","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1007\/s00198-011-1742-7","article-title":"Comparable outcomes in fracture reduction and bone properties with RANKL inhibition and alendronate treatment in a mouse model of osteogenesis imperfecta","volume":"23","author":"Bargman","year":"2012","journal-title":"Osteoporos Int"},{"issue":"3","key":"10.1016\/j.pcl.2014.08.010_bib69","first-page":"183","article-title":"First use of the RANKL antibody denosumab in osteogenesis imperfecta type VI","volume":"12","author":"Semler","year":"2012","journal-title":"J\u00a0Musculoskelet Neuronal Interact"},{"issue":"5","key":"10.1016\/j.pcl.2014.08.010_bib70","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1210\/er.2011-1060","article-title":"Sclerostin and dickkopf-1 as therapeutic targets in bone diseases","volume":"33","author":"Ke","year":"2012","journal-title":"Endocr Rev"},{"issue":"1","key":"10.1016\/j.pcl.2014.08.010_bib71","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/jbmr.1717","article-title":"Sclerostin antibody improves skeletal parameters in a brtl\/+ mouse model of osteogenesis imperfecta","volume":"28","author":"Sinder","year":"2013","journal-title":"J\u00a0Bone Miner Res"},{"issue":"20","key":"10.1016\/j.pcl.2014.08.010_bib72","doi-asserted-by":"crossref","first-page":"4013","DOI":"10.1093\/nar\/28.20.4013","article-title":"Hammerhead ribozymes selectively suppress mutant type I collagen mRNA in osteogenesis imperfecta fibroblasts","volume":"28","author":"Dawson","year":"2000","journal-title":"Nucleic Acids Res"},{"issue":"7","key":"10.1016\/j.pcl.2014.08.010_bib73","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.exphem.2010.04.008","article-title":"Amelioration of a mouse model of osteogenesis imperfecta with hematopoietic stem cell transplantation: microcomputed tomography studies","volume":"38","author":"Mehrotra","year":"2010","journal-title":"Exp Hematol"},{"issue":"3","key":"10.1016\/j.pcl.2014.08.010_bib74","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/6529","article-title":"Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta","volume":"5","author":"Horwitz","year":"1999","journal-title":"Nat Med"}],"container-title":["Pediatric Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031395514001485?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031395514001485?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,15]],"date-time":"2019-08-15T07:04:39Z","timestamp":1565852679000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031395514001485"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":74,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["S0031395514001485"],"URL":"https:\/\/doi.org\/10.1016\/j.pcl.2014.08.010","relation":{},"ISSN":["0031-3955"],"issn-type":[{"value":"0031-3955","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Update on the Evaluation and Treatment of Osteogenesis Imperfecta","name":"articletitle","label":"Article Title"},{"value":"Pediatric Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pcl.2014.08.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}